BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Wednesday, April 24, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
May 14, 2003
View Archived Issues
Microscience and Abgenix to develop monoclonal antibodies for infectious disease
Read More
SBIR grant to fund Avanir antibody development for cytomegalovirus
Read More
BioSante announces positive phase II/III results for Bio-E-Gel
Read More
Neurochem licenses preclinical diabetes technology to Innodia
Read More
Phase II testing commences for Glucoprime
Read More
Isis expands and advances development pipeline
Read More
Antisoma: Q1 developments
Read More
Migration inhibitory factor (MIF): a novel target for wound healing
Read More
Vanilloid receptor antagonism prevents DSS-induced colitis in rats
Read More
Genaera reports early findings for squalamine in AMD
Read More
Antiviral activity of new ribonucleoside analogue
Read More
Cheil Jedang claims two series of COX-2 inhibitors for use in gastrointestinal disorders
Read More
Novel PLA2 inhibitors with antiinflammatory and analgesic activity claimed by Nippon Soda
Read More
Melanocortin receptor modulators in early development at Neurocrine Biosciences
Read More
NeuroSearch describes AMPA receptor modulators, their preparation and biological activity
Read More
Recent Shionogi patent covers new DHODH inhibitors
Read More
Mitsubishi Pharma scientists prepare and test new chemokine receptor antagonists
Read More
Novel aldose reductase inhibitors covered by Otsuka patent
Read More
Takeda presents vanilloid agonists for urinary incontinence and pain
Read More
Raptiva rheumatoid arthritis trial discontinued
Read More
Epimmune and Anosys enter definitive merger agreement
Read More
Preliminary results from phase IIb trial of renzapride in c-IBS
Read More
FDA approves revised labeling for Flonase
Read More
Phase II study suggests pirfenidone may be more effective in IPF than prednisone
Read More
3M submits Aldara sNDA for actinic keratosis
Read More
IND submitted for Hynic-Annexin V
Read More
BioVex signs letter of intent with NIAID for development of HIV vaccine
Read More
HCT-1026 pharmacokinetic results in humans
Read More